Вариабельность сердечного ритма в динамике радиойодтерапии болезни Грейвса: патогенетические аспекты и диагностическая ценность
Диссертация
Кардиальные проявления болезни Грейвса являются наиболее яркими симптомами заболевания и описаны подробно. В том числе выявлено снижение вариабельности ритма сердца на фоне тиреотоксикоза. В исследованиях Inukai, T. et all (1998), а потом и Osman F. et all (2004) показали восстановление вариабельности после достижения стойкого эутиреоза в процессе терапии тиростатиками. Роль вегетативной нервной… Читать ещё >
Список литературы
- Александров В.Н., Клетскин С. З. с соавт. Автономная нервная система у больных токсическим зобом// Проблемы эндокринологии 1985, 31(6):21−25
- Баевский P.M. Анализ вариабельности сердечного ритма в космической медицине// Физиология человека, 2002 28(2): 70−82
- Баевский P.M., Иванов Г. Г. Вариабельность сердечного ритма: теоретические аспекты и возможности клинического применения //Ультразвуковая и функциональная диагностика. 2001. № 3. С. 108
- Баевский P.M., Иванов Г. Г., Чирейкин JI.B. с соавт. Анализ вариабельности сердечного ритма при использовании различных электрокардиографических систем. Методические рекомендации// Уральский кардиологический журнал, 2001 № 1, с.17−31
- Баевский P.M., Кириллов О. И., Клецкин С. М. Математический анализ изменений сердечного ритма при стрессе. М: Наука 1984, -254с.
- Балаболкин М.И., Е.М. Клебанова, В. М. Креминская. Дифференциальная диагностика и лечение эндокринных заболеваний (руководство). М. «Медицина», 2002
- Балаболкин М.И., Клебанова Е. М., Креминская В. М. Фундаментальная и клиническая тиреоидология. М: Медицина 2007, 816с.
- Бондарь Т.Н. Субклинические нарушения функции щитовидной железы.// Annals of Mechnikov Institute 2008, 4:9−13
- Вариабельность сердечного ритма. Теоретические аспекты и практическое применение. Тезисы международного симпозиума 12−14 сентября 1996 г. Ижевск. 1996. С.225
- Вейн A.M., Каменицкая Б. И., Хаспекова Н. Б. с соавт. Ритм сердца при кардиоваскулярных нарушениях невротического генеза// Кардиология 1987, 9: 85−89
- Герасимов Г. М., Мельниченко Г. А., Петунина H.A., Федак И. Р. Современные представления о лечении тиреотоксикоза радиоактивным йодом. Комментарии к рекомендациям европейских экспертов. Шроблемы эндокринологии, 1997 № 1
- Дедов И.И., Мельниченко Г. А., Пронин B.C. и др. Клиника и диагностика эндокринных нарушений: Учебно-методическое пособие. — М., 2005.
- Егоров П.П., Цфсман А. З. Радиоактивный йод в диагностике и лечении заболеваний щитовидной железы. -М.:Медгиз, 1962. 192с.
- Михайлов В.М. Вариабельность ритма сердца. Опыт практического применения метода. Иваново, 2000. -200с.
- Петунина Н. Прогностические факторы и оптимизация методов лечения диффузного токсического зоба Текст.: автореф. дис.. д-ра мед. наук / А. М.: ГУ Эндокринол. Науч. центр РАМН, 2004. — 48 с.
- Рябыкина Г. В., Соболев A.B. Вариабельность ритма сердца.//М: Стар Ко, 1998, — 196с.
- Фадеев В.В. Заболевания щитовидной железы в регионе легкого йодного дефицита: эпидемиология, диагностика, лечение. — М. '.Издательский дом Видар-М, 2005. 240с.
- Фадеев В.В., Дроздовский Б. Я., Гусева Т. Н. с соавт. Отдаленные результаты лечения токсического зоба радиоактивным 1311// проблемы эндокринологии 2005, 51(1):3−10
- Фадеев В.В. Болезнь Грейвса.// РМЖ, Том 10 № 27, 2002
- Фадеев В.В. К 170-летию описания Роберта Грейвса // Клиническая и экспериментальная тиреоидология. 2006. № 2.С. 5−8.
- Хаютин В.М., Лукошкова Е. В. Колебание частоты сердцебиений: спектральный анализ.// Вестник аритмологии 2002, 26: 21−25
- Цыб А.Ф., Древаль A.B., Гарбузов П. И. Радиойодтерапия тиреотоксикоза. Руководство. М: Геотар-Медиа 2009, -160с.
- Эндокринология. Национальное руководство. Под ред. Дедова И. И., Мельниченко Г. А. М: Геотар-Медиа 2008, 1072с.
- Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat to beat cardiovascular control. Science. 1981−213:220−222
- Alexander E.K., Larsen P.R. High Dose 1311 Therapy for the Treatment of Hyperthyroidism Caused by Graves' Disease// J Clin Endocrinol Metab 2002 87(3): 1073−1077
- Allahabadia A, Daykin J, Sheppard MC et al. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.// J Clin Endocrinol Metab 2001- 86:3611−7
- American Association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism // Endocrine practice. 2002. — Vol.8. — N.6. — P.458−469
- Andrade V.A., Gross J.L., Maia A.L. The Effect of Methimazole Pretreatment on the Efficacy of Radioactive Iodine Therapy in Graves' Hyperthyroidism: One-Year Follow-Up of a Prospective, Randomized Study// J Clin Endocrinol Metab 2001 86(8):3488−3493
- Bartalena L, Marcocci C, Bogazzi F et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998−338:73−8.
- Bogazzi F, Bartalena L, Campomori A et al. Treatment with Lithium Prevents Serum Thyroid Hormone Increase after Thionamide Withdrawal and Radioiodine Therapy in Patients with Graves' Disease// J Clin Endocrinol Metab 2002, 87: 4490−4495
- Bonnema S.J., Bennedbak F.N., Veje A. et al. Continuous Methimazole Therapy and Its Effect on the Cure Rate of Hyperthyroidism Using Radioactive1. dine: An Evaluation by a Randomized Trial// J Clin Endocrinol Metab 2006, 91(8): 2946−2951
- Burch H.B., Solomon B.L., Cooper D.S. et al. The Effect of Antithyroid Drug Pretreatment on Acute Changes in Thyroid Hormone Levels after 1311 Ablation for Graves' Disease// J Clin Endocrinol Metab 2001, 86(7): 3016−3021
- Burggraaf, J., Tulen, J.H.M., Lalezari, S., Schoemaker, R.C., De Meyer, P.H.E.M., Meinders, A.E., Cohen, A.F. & Pijl, H. (2001) Sympathovagal imbalance in hyperthyroidism. American Journal of Physiology. Endocrinology and Metabolism, 281, El90-E195
- Cairoli. VJ,. Crout JR. Role of autonomic nervous system in patients tachycardia of experimental hyperthyroidism// Journal of Pharmacology And Experimental Therapeutics, Vol. 158, Issue 1, 55−65, 1967
- Casu M, Cappi C, Patrone V, Repetto E Sympatho-vagal control of heart rate variability in patients treated with suppressive doses of L-thyroxine for thyroid cancer.// Eur J Endocrinol. 2005 Jun-152(6):819−24
- Catrgi B., Leprat f., Guyot M. et al. Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and of other possible factors affecting outcome// J Clin Endocrinol Metab 1999, 141(2): 117−121
- Chen JL, Tseng YJ, Chiu HW et al. Nonlinear analysis of heart rate dynamics in hyperthyroidism.// Physiol Meas. 2007 Apr-28(4):427−37
- Cook JR, JT Bigger Jr, RE Kleiger et al. Effect of atenolol and diltiazem on heart period variability in normal persons// J Am Coll Cardiol, 1991- 17:480−484
- Cooper DS. Hyperthyroidism// Lancet 2003, 362(9382): 459−468
- Doi S., Loutfl I., Al-Shoumer K. A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism.// BMC Nucl Med. 2001- 1: 1
- Ecksberg D.L. Sympathovagal balance. A critical appraisal.// Circulation 1997, 96:3224−32
- El Refaei S.M., Shawkat W. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.// Nucl Med Commun. 2008 Jul- 29(7):642−8
- Erem C., Kandemir N., HaciHasanoglu A. et al. Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.// Endocrine. 2004 0ct-25(l):55−60
- Eustatia-Rutten CF, Corssmit EP, Heemstra KA et al. Autonomic nervous system function in chronic exogenous subclinical thyrotoxicosis and the effect of restoring euthyroidism.// J Clin Endocrinol Metab. 2008 Jul-93(7):2835−41
- Fazio, S., Palmieri, E.A., Lombardi, G. & Biondi, B. (2004) Effects of thyroid hormone on the cardiovascular system. Recent Progress in Hormone Research, 59, 31−50
- Franklyn J.A. Thyrotoxicosis// Clin.Med. 2003. — Vol.3. — P. 11−15
- Franklyn JA, Maisonneuve P, Sheppard M et al. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study.// Lancet 1999−3 53:2111−5
- Franklyn, J.A., Maisonneuve, P., Sheppard, M.C., Betteridge, J. & Boyle, P. (1998) Mortality after the treatment of hyperthyroidism with radioactive iodine. New England Journal of Medicine, 338, 712−718
- Franklyn, J.A., Sheppard, M.C. & Maisonneuve, P. (2005) Thyroid function and mortality in patients treated for hyperthyroidism. Journal of the American Medical Association, 294, 71−80
- Fraser A, Hess ME: Parasympathetic responses in hyperthyroid rats. J. Pharmacol Exp Ther, 1969. 170: 1−9
- Funatsu T. Hemodynamics of hyperthyroidism. The effects of autonomic nervous blocking and anti-thyroid drug treatment//Jpn Heart J. 1976 Jan-17(l):12−24
- Giovanella L., De Palma D., Ceriani' L et al. Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results.// Radiol Med (Torino). 2000 Dec-100(6):480−3
- Girard, A., Hugues, F.-C., Le Jeunne, C. & Elghozi, J.-L. (1998) Short-term variability of blood pressure and heart rate in hyperthyroidism. Clinical Autonomic Research, 8, 181−186
- Goichot B, Brandenberger G, Vinzio S et al. Sympathovagal response to orthostatism in overt and in subclinical hyperthyroidism.// J Endocrinol Invest. 2004 Apr-27(4):348−52
- Heimbach D. M. and J. R. Crout. Effect of Atropine on the Tachycardia of Hyperthyroidism//Arch Intern Med, March 1, 1972- 129(3): 430−432
- Howarlh D- Epstein M- Lan L et al. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study// Eur J Nucl Med 2001 -28(10): 1489−95
- Huykuru H.V., Jokinen V., Syvanne M. et al. Measurement of heart rate variability: a clinical tool or research toy?// J Am Coll Cardiol 1999? 34:1 878 188 363. lagaru a., McDougall I.R. Treatment of Thyrotoxicosis// J Nucl Med 2007, 48(3): 379−389
- Inukai, T., Takanashi, K., Kobayashi, H., Fujiwara, Y., Tayama, K., Aso, Y. & Takemura, Y. (1998) Power spectral analysis of variations in heart rate in patients with hyperthyroidism or hypothyroidism. Hormone and Metabolic Research, 30: 531−535
- Isselt van J.W., van Dongen A.J.The current status of radioiodine therapy for benign thyroid disorders.// Hell J Nucl Med. 2004 May-Aug-7(2):104−10
- Jose AD, Collison D. The normal range and determinants of the intrinsic heart rate in man. Cardiovascular Research. 1970- 4: 160−167
- ICahaly G. J. and W. H. Dillmann. Thyroid Hormone Action in the Heart//?ndocr. Rev., 2005- 26(5): 704 728
- Klein I. and S. Danzi. Thyroid Disease and the Heart//Circulation, 2007- 116(15): 1725 1735
- Konishi J. Radioiodine treatment of Graves' disease —for its wider indication and application in Japan.//Nippon Rinsho. 2006 Dec-64(12):2257−61
- La Rovere M.T., Pinna G.D., Hohnloser S.H. et al. Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials// Circulation2001- 103 -2072−2077
- Leslie W.D., Ward L., Salamon E.A. et al. A Randomized Comparison of Radioiodine Doses in Graves' Hyperthyroidism// J Clin Endocrinol Metab 2003, 88(3): 978−983
- Lind P. Strategies of radioiodine therapy for Graves' disease.// Eur J Nucl Med Mol Imaging. 2002 Aug-29 Suppl 2: S453−7
- Ma C, Kuang A, Xie J, Liu GJ. Radioiodine treatment for pediatric Graves' disease. Cochrane Database of Systematic Reviews 2008, Issue 3
- Maciel B.C., Gallo Junior J., Marin-Neto J.A., Zanini-Maciel L.M. Depressed respirator)' sinus arrhythmia: additional evidence for impairment of vagal activity in human hyperthyroidism.// Braz J Med Biol Res. 1990−23(2): 195−7
- Maciel, B.C., Gallo, L. Jr, Marin Neto, J.A., Maciel, L.M.Z., Alves, M.L.D., Paccola, G.M.F. & lazigi, N. () The role of the autonomic nervous system in the resting tachycardia of human hyperthyroidism. Clinical Science, 1987, 72: 239 244
- Malliani A, Julien C, Billman GE, Cerutti S, Piepoli MF, Bernardi L, Sleight P, Cohen MA. Tan CO, Laude D, Elstad M, Toska K, Evans JM, Eckberg DL. Cardiovascular variability is/is not an index of autonomic control of circulation. J
- Appl Physio! 101: 684−688, 2006
- Malliani A, Pagani M, Lombardi F et all. Cardiovascular neural regulation explored in frequency domain// Circulation 1991, 84: 1482−92
- Malliani A. The pattern of sympatovagal balance explored in frequency domain// News Physiol Sci 1999, 14:111−7
- Metso S., Jaatinen P., Huhtala H et al. Long-term follow-up study of radioiodine treatment of hyperthyroidism.// Clin Endocrinol (Oxf). 2004 Nov-61(5):641−8
- Mudrikova T., Jurcova V., Tokarcikova A., et al. Effect of bisoprolol on heart rate variability in patients with hyperthyroidism Vnitr Lek. 2000 Feb-46(2):87−91
- Muhammad W., Faaruq S., Hussain A. et al. Quantitative analysis of the factors responsible for over or under dose of 1311 therapy patients of hyperthyroidism// Radiat Prot Dosimetry 2008 128(1): 90−97
- Northcote RJ, MacFarlane P, Kesson CM et al. Continuous 24-hour electrocardiography in thyrotoxicosis before and after treatment.// Am Heart J. 1986 Aug-! 12(2):339−44
- Oknin V. L, Vnotchenko S.L., Sadekov R.K. A comparative analysis of the function of the autonomic nervous system in patients with thyrotoxicosis and autonomic crises.// Ter Arkh. 1994−66(10):29−32
- Osman, F., Franklyn, J.A., Daykin, J., Chowdhary, S., Holder, R.L., Sheppard, M.C. & Gammage, M.D. (2004) Heart rate variability and turbulence in hyperthyroidism before, during, and after treatment. American Journal of1. Cardiology, 94: 465−469
- Psrati G, di Rienzo M, Castiglioni P, and Mancia G- Taylor JA and Studinger P, Poim: Counterpoint: Cardiovascular variability is/is not an index of autonomic conlrol of circulation. J Appl Physiol 2006, 101: 676−682
- Pomeranz M, Macaulay RJB, Caudill MA, Kutz I, Adam D, Gordon D, KilboiTi KIvI, Barger AC, Shannon DC, Cohen RJ, Benson M. Assessment ofautonomic function in humans by heart rate spectral analysis. Am J Physiol. 1985−248:H151 -HI 53
- R Vaicavi, C Menozzi, E Roti, M Zini, G Lolli et al. Sinus node function in hyperthyroid patients// J Clin Endocrinol Metab. 1992 Jul-75(l):239−42
- Read CH Jr, Tansey MJ, Menda Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients. J Clin Endocrinol Metab 2004, 89:4229−33
- R i esc o-Ei zagui rre G., Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications// Eur J Endocrin 2006, 1554): 495 512
- Ron E, Dcody MM, Becker DV et al. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study
- Group.// JAMA 1998−280:347−55
- Royal College of Physicians. Radioiodine in the management of benign thyroid disease: clinical guidelines. Report of a Working Party. London: RCP, 2007
- Sabri O, Zimny M, Schulz G et al. Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication.// J Clin Endocrinol Metab 1999, 84(4): 1229−1233
- Safa-Tisseront V., Ponchon P., Laude D., Elghozi J.L. Autonomic contribution to the blood pressure and heart rate variability changes in early experimental hyperthyroidism.// J Hypertens. 1998 Dec-16(12 Pt 2):1989−92
- Singer R.B. Long-term comparative mortality in hyperthyroid patients treated with radio-iodine, a cohort study in England.// J Insur Med. 2001 -33(2):i 33--7
- Sri dam a V, DeGroot LJ. Treatment of Graves' disease and the course of ophthalmopathy. Am J Med 1989−87:70−73
- Tallstedi. L, Lundell G, Blomgren H et al. Does early administration of thyroxine reduce ihe development of Graves' ophthalmopathy after radioiodine treatment? Eur J Endocrinol 1994−130:494−7
- Tallsledr. L. Lundell G, Torring O et al. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. N Engl J1. Med 1992−326:1733−8
- Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation, 1996, 93: 1043−1065
- Taylor i.A., Carr D.L., Myers C.W. et al. Mechanisms underlying very-low frequency RR--interval oscillation in humans// Circulation 1998, 98:547−555
- W R Wilson, E O Theilen, J H Hege and M R Valenca. Effects of beta-adrenergic receptor blockade in normal subjects before, during, and after triiodothyronine-induced hypermetabolism. //J. Clin. Invest. 1966, 45(7): 11 591 169
- Walter M.A., Christ-Crain M., Schindler C. et al. Outcome of radioiodine therapy without, on or 3 days off Carbimazole: a prospective interventional three-group comparison.// Eur J Nucl Med Mol Imaging. 2006 Jun- 33(6):730−7
- Wartofsky L, Glinoer D, Solomon B et al. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. //Thyroid 1991- 1:129−3 5
- Weetman A.P. Etiology, diagnosis and treatment of Grave’s disease // Thyroid international 2003. — № 2
- Weetman A.P. Grave’s disease // N Engl J Med 2000, 343:1236−48
- Yamashka Y., Yamane K., Tamura T. et al. Onset age is associated with outcome of radioiodine therapy in Graves' disease// Endocrine Journal 2004, 51(2): 127−132